Veterans Health Administration NTP Goes Live

Open PDF
Stock MACH7 Technologies Ltd (M7T.ASX)
Release Time 31 Oct 2025, 8:50 a.m.
Price Sensitive Yes
 Mach7 Technologies' NTP Goes Live
Key Points
  • Mach7 Technologies' Vendor Neutral Archive (VNA) and eUnity Diagnostic Viewer selected for Veterans Health Administration's National Teleradiology Program (NTP)
  • Phase 1 rollout expected to interpret 1.0-1.5m studies annually with a potential Total Contract Value of A$11.7M
  • Successful Phase 1 rollout opens up potential for Phase 2 expansion into the VHA hospital network
Full Summary

Mach7 Technologies Limited (ASX:M7T), a company specialising in innovative medical imaging software solutions, has announced positive progress executing Phase 1 of its engagement with the Veterans Health Administration's (VHA) National Teleradiology Program (NTP). The NTP is the Veterans Affairs in-house teleradiology service which provides 24x7 services to 125 unique sites across all 18 Veterans Integrated Services Networks (VISNs). As one of several subcontractors to the prime vendor, Frontier Acquisitions LLC, Mach7 is providing its Vendor Neutral Archive (VNA), eUnity Diagnostic Viewer and Professional Services as part of a best of breed Next Generation PACS solution. The Next Generation PACS program consists of two major phases. Under Phase 1, Mach7's VNA and eUnity Viewer form the core of the NTP's Next Generation PACS which is expected to interpret 1.0-1.5m studies annually. This phase has a potential Total Contract Value (TCV) of A$11.7M based on a fee per study subscription licence over a 3-year term. Mach7 has completed initial milestones for a limited go-live in mammography and telestroke with a plan for a phased rollout for the remainder of Phase 1 through the month of November. A successful rollout of Phase 1 opens up the potential for a Phase 2 expansion into the VHA hospital network beyond the NTP.

Guidance

Phase 1 of the NTP engagement is expected to interpret 1.0-1.5m studies annually with a potential Total Contract Value of A$11.7M over a 3-year term.

Outlook

A successful rollout of Phase 1 opens up the potential for a Phase 2 expansion into the VHA hospital network beyond the NTP.